| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.35 | 4e-10 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-07 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.3 | 5e-06 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |